高效的双功能酸用于瘤免疫疗法,通过同时激活T细胞和阻断PD-L1免疫检查点
Aixian Zheng1, Xiaorong Wang1,2, Yaning Wu1,2
1The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350007, P. R. China.
ACS applied materials & interfaces
|March 15, 2025
概括
一种新的双功能 (Bi-pep) 激活T细胞并阻断PD-L1,增强瘤免疫疗法. 这种具有显著的潜力,可以通过促进T细胞介导的瘤细胞杀死来改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 免疫检查点抑制剂 (ICI),如PD-1/PD-L1抗体,在瘤免疫治疗中显示出有前途.
- 然而,由于T细胞活动不足,观察到有限的应答率.
- 基于抗体的疗法存在挑战,包括高成本和复杂的准备.
研究的目的:
- 开发一种基于非抗体的策略,以克服当前ICB治疗的局限性.
- 为增强瘤治疗构建一个双功能 (Bi-pep).
- 研究Bi-pep在激活T细胞和阻断PD-L1.1中的双重作用.
主要方法:
- 构建了一个新的双功能 (Bi-pep).
- 对Bi-pep阻断PD-1/PD-L1通路的能力的评估.
- 评估Bi-pep激活和促进T细胞增殖的能力.
- 在体内研究使用皮下和正管瘤模型.
主要成果:
- 构建的Bi-pep有效地阻断了PD-1/PD-L1免疫抑制途径.
- 据证明,Bi-pep直接有效地促进了T细胞的激活和增殖.
- 观察到T细胞介导的瘤细胞杀死显著增强.
- 在小鼠模型中,Bi-pep显著抑制瘤生长和延长存活时间.
结论:
- 双功能 (Bi-pep) 为瘤免疫疗法提供了一个有前途的非抗体方法.
- 双的双重作用机制可以增强抗瘤免疫力.
- 这一策略对未来在癌症治疗中的生物医学应用具有重大潜力.
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:30Cancer Vaccines
319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319